Circassia Pharmaceuticals PLC Company Profile (LON:CIR)

About Circassia Pharmaceuticals PLC

Circassia Pharmaceuticals PLC logoCircassia Pharmaceuticals plc is a specialty biopharmaceutical company focused on allergy and respiratory diseases. The Company operates through three segments: Allergy, which relates to a range of immunotherapy development products for the treatment of allergy; NIOX, which relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO), and Respiratory, which relates to the portfolio of asthma and chronic obstructive pulmonary disease product candidates. Its next-generation immunotherapy is in Phase III testing for cat allergy. Its lead asthma treatment targets substitution of GlaxoSmithKline's (GSK's) Flixotide pMDI. It is developing therapies targeting direct substitution of Seretide pMDI and Serevent pMDI. The Company is also developing a range treatment, including a fixed dose triple combination containing an inhaled corticosteroid, long-acting beta agonist and long-acting muscarinic antagonist.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: CIR
  • CUSIP:
Key Metrics:
  • Previous Close: $1.07
  • 50 Day Moving Average: $88.69
  • 200 Day Moving Average: $90.61
  • 52-Week Range: £2,848,890 - GBX 78.45
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $243.58B
  • Outstanding Shares: 284,889,000
Additional Links:

Analyst Ratings

Consensus Ratings for Circassia Pharmaceuticals PLC (LON:CIR) (?)
Ratings Breakdown: 4 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: GBX 175.83

Analysts' Ratings History for Circassia Pharmaceuticals PLC (LON:CIR)
Show:
DateFirmActionRatingPrice TargetDetails
2/24/2017Peel HuntLower Price TargetAddGBX 160 -> GBX 150View Rating Details
1/17/2017J P Morgan Chase & CoReiterated RatingNeutralView Rating Details
9/27/2016Numis Securities LtdReiterated RatingBuyGBX 150View Rating Details
6/21/2016Barclays PLCInitiated CoverageOverweightGBX 410 -> GBX 170View Rating Details
6/21/2016Stifel NicolausDowngradeHoldView Rating Details
6/21/2016Royal Bank of CanadaDowngradeSector PerformerGBX 430 -> GBX 105View Rating Details
5/18/2015Canaccord GenuityReiterated RatingBuyGBX 325View Rating Details
5/15/2015Shore CapitalReiterated RatingBuyView Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for Circassia Pharmaceuticals PLC (LON:CIR)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Circassia Pharmaceuticals PLC (LON:CIR)
Current Year EPS Consensus Estimate: $-30.05 EPS

Dividends

Dividend History for Circassia Pharmaceuticals PLC (LON:CIR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Circassia Pharmaceuticals PLC (LON:CIR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/18/2015Swingland,CharlesInsiderSell754,548GBX 320£2,414,553.60
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Circassia Pharmaceuticals PLC (LON:CIR)
DateHeadline
News IconHalfords Group PLC (LON:HFD) Receives Sell Rating From Peel Hunt Analysts (LON:CIR)
techknowbits.com - February 26 at 8:31 AM
trustnet.com logoBroker Forecast - Peel Hunt issues a broker note on Circassia Pharmaceuticals Plc (LON:CIR)
www.trustnet.com - February 24 at 9:31 PM
News IconUS and China Asthma and COPD Drugs Market: Pin-Point Analysis of Industry Trends & Recent Improvement For 2024 - Medgadget (blog) (LON:CIR)
www.medgadget.com - February 24 at 12:31 PM
marketexclusive.com logoAnalyst Activity – Peel Hunt Lowers Its Price Target On Circassia Pharmaceuticals PLC (LON:CIR) to GBX 150 - Market Exclusive (LON:CIR)
marketexclusive.com - February 24 at 12:31 PM
sbwire.com logoRhino-Conjunctivitis Global Clinical Trials Review, H2, 2016 - New Market Study Published (LON:CIR)
www.sbwire.com - February 22 at 12:06 PM
finanznachrichten.de logoINVESCO PERPETUAL SELECT TRUST PLC - Half-year Report (LON:CIR)
www.finanznachrichten.de - February 1 at 4:38 PM
trustnet.com logoCircassia Pharma Plc (CIR) (LON:CIR)
www.trustnet.com - January 31 at 4:43 PM
capitalcube.com logoCircassia Pharmaceuticals Plc – Value Analysis (LONDON:CIR) : January 27, 2017 (LON:CIR)
www.capitalcube.com - January 27 at 5:41 PM
capitalcube.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : CIR-GB : January 26, 2017 (LON:CIR)
www.capitalcube.com - January 26 at 5:20 PM
sbwire.com logoAsthma and COPD Drugs in U.S. and China Industry Analysis & Forecast Available in Latest Report (LON:CIR)
www.sbwire.com - January 25 at 10:29 PM
News IconJefferies Group Reaffirms Buy Rating for Shire PLC (SHP) (LON:CIR)
myhealthbowl.com - January 5 at 4:45 PM
News IconBroker Forecast - JP Morgan Cazenove issues a broker note on Circassia Pharmaceuticals Plc (LON:CIR)
www.youinvest.co.uk - January 4 at 5:21 PM
News IconTotal Voting Rights (Cairn Energy plc) (LON:CIR)
www.newsoneplace.com - December 31 at 4:22 PM
News IconTotal Voting Rights (Circassia Pharmaceuticals plc) (LON:CIR)
www.newsoneplace.com - December 30 at 4:43 PM
News IconPatient Capital A new way of funding the commercialisation of early-stage UK science (LON:CIR)
docplayer.net - December 22 at 4:26 PM
News IconFollow The Ratings: Barr A G PLC (LON:BAG) Stock Hold Rating Reconfirmed at HSBC; The Target Price per Share ... - Thorold News (LON:CIR)
www.whatsonthorold.com - December 21 at 10:01 PM
News IconAsthma and COPD Drugs Market China Poised to Witness Strong Growth by 2024 (LON:CIR)
reports.pr-inside.com - December 21 at 5:01 PM
News IconToday's Rating On Watch: Numis Reaffirms GBX 575.00 Price Target On Barr A G PLC (LON:BAG), Reaffirms "Add ... - Thorold News (LON:CIR)
www.whatsonthorold.com - December 17 at 4:31 PM
News IconAsthma and COPD Drugs Market Detailed Analysis and Forecast by 2024 (LON:CIR)
www.medgadget.com - December 17 at 2:46 AM
News IconRating Worth Watching: Berenberg Reports Upgrade of Barr A G PLC (LON:BAG) with GBX 480.00 Target - Thorold News (LON:CIR)
www.whatsonthorold.com - December 16 at 9:44 PM
News IconGlobal Opportunity in The U.S. and China Asthma and COPD Drugs Market (LON:CIR)
reports.pr-inside.com - December 16 at 2:47 AM
News IconOutstanding Analyst Ratings For Circassia Pharmaceuticals (LON:CIR) - UK Market News (LON:CIR)
www.ukmarketnews.co.uk - December 13 at 4:57 PM
capitalcube.com logoCircassia Pharmaceuticals Plc – Value Analysis (LONDON:CIR) : December 7, 2016 (LON:CIR)
www.capitalcube.com - December 7 at 4:56 PM
capitalcube.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : CIR-GB : December 6, 2016 (LON:CIR)
www.capitalcube.com - December 6 at 11:57 AM
lse.co.uk logoTotal Voting Rights Update - London South East (registration) (blog) (LON:CIR)
www.lse.co.uk - December 1 at 4:28 PM
publicnow.com logoTotal Voting Rights Update (LON:CIR)
www.publicnow.com - December 1 at 4:28 PM
newsmaker.com.au logoAllergic Rhinitis Market Revenue Predicted To Go Up by 2016 - 2026 (LON:CIR)
www.newsmaker.com.au - November 30 at 8:21 AM
News IconEDINBURGH INVESTMENT TRUST PLC - Half-year Report (LON:CIR)
uk.advfn.com - November 24 at 12:07 PM
News IconCircassia Pharmaceuticals Plc CIR Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (LON:CIR)
www.bioportfolio.com - November 17 at 11:31 AM
News IconAsthma global market report,analysis pipeline review, H2 2016 illuminated by new report (LON:CIR)
www.whatech.com - November 16 at 9:44 AM
News IconAllergic Rhinitis Market Headed for Growth and Global Expansion by 2016 - 2026 (LON:CIR)
www.prurgent.com - November 16 at 9:44 AM
News IconDiscover the global asthma market report pipeline review, H2 2016 (LON:CIR)
www.whatech.com - November 15 at 9:30 AM
sbwire.com logoAllergic Rhinitis Market: Global Industry Analysis and Forecast 2016 - 2026 (LON:CIR)
www.sbwire.com - November 11 at 1:40 PM
News IconAllergic Rhinitis Market: Increasing Prevalence Rate of Allergy is Anticipated to Drive Global Market by 2026 (LON:CIR)
www.prurgent.com - November 10 at 10:15 PM
News IconProven strong business model (LON:CIR)
www.imperialinnovations.co.uk - October 28 at 8:36 AM
News IconHelsinn Group Creates $50 Million Investment Fund (LON:CIR)
www.mpo-mag.com - October 18 at 4:09 PM
4-traders.com logoImperial Innovations : Swings To Annual Loss On Circassia Hit (LON:CIR)
www.4-traders.com - October 13 at 4:08 PM
capitalcube.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : CIR-GB : October 7, 2016 (LON:CIR)
www.capitalcube.com - October 7 at 9:10 AM
News IconAllergic Asthma - Pipeline Review, H2 2016 - New Market Study Published (LON:CIR)
reports.pr-inside.com - September 30 at 9:15 AM
News IconExplore Global grass pollen allergy pipeline 2016 market analysis review (LON:CIR)
www.whatech.com - September 27 at 4:15 PM
reuters.com logoUK Stocks-Factors to watch on Sept. 27 (LON:CIR)
www.reuters.com - September 27 at 8:49 AM
News IconGW Pharmaceuticals PLC- ADR 51% Potential Upside Now Implied by Cantor Fitzgerald (LON:CIR)
canalcncarauca.com - September 27 at 8:49 AM
4-traders.com logoCircassia Pharmaceuticals : Interim Loss Balloons After Disappointing Cat Allergy Trial (LON:CIR)
www.4-traders.com - September 27 at 8:49 AM
News IconGW Pharmaceuticals plc's (GWP) Hold Rating Reiterated at Numis Securities Ltd (LON:CIR)
magseriesusa.net - September 27 at 8:49 AM
News IconAnalysts At Numis Securities Indicated Circassia Pharmaceuticals (LON:CIR) As Buy (LON:CIR)
diariocatolico.net - September 27 at 8:49 AM
capitalcube.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : CIR-GB : September 27, 2016 (LON:CIR)
www.capitalcube.com - September 27 at 8:49 AM
biz.yahoo.com logoHalf Year 2016 Circassia Pharmaceuticals PLC Earnings Release - Time Not Supplied (LON:CIR)
biz.yahoo.com - September 27 at 8:49 AM
einnews.com logoCircassia: Consumption, Demand, Sales, Competitor and Forecast 2016 – 2021 (LON:CIR)
world.einnews.com - September 24 at 8:28 AM
4-traders.com logoCircassia Pharmaceuticals PLC : half-yearly earnings release (LON:CIR)
www.4-traders.com - September 22 at 4:24 PM
live-pr.com logoNew Study: Aerocrine AB - Medical Equipment - Deals and Alliances Profile (LON:CIR)
www.live-pr.com - September 15 at 11:04 AM

Social

What is Circassia Pharmaceuticals PLC's stock symbol?

Circassia Pharmaceuticals PLC trades on the London Stock Exchange (LON) under the ticker symbol "CIR."

Where is Circassia Pharmaceuticals PLC's stock going? Where will Circassia Pharmaceuticals PLC's stock price be in 2017?

6 brokers have issued 1-year price objectives for Circassia Pharmaceuticals PLC's shares. Their forecasts range from GBX 105 to GBX 375. On average, they expect Circassia Pharmaceuticals PLC's share price to reach GBX 175.83 in the next twelve months.

When will Circassia Pharmaceuticals PLC announce their earnings?

Circassia Pharmaceuticals PLC is scheduled to release their next quarterly earnings announcement on Monday, March, 20th 2017.

How do I buy Circassia Pharmaceuticals PLC stock?

Shares of Circassia Pharmaceuticals PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Circassia Pharmaceuticals PLC stock cost?

One share of Circassia Pharmaceuticals PLC stock can currently be purchased for approximately GBX 86.


Last Updated on 2/27/2017 by MarketBeat.com Staff